ARCHIVES

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

This article is from The Cancer Letter archive.

Vol. 29 No. 04 | January 24, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

CPSC Relies On NCI Findings For New Policy

July 21, 1978